Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CEACAM6 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA586836
Description
Purity is > 95% by SDS-PAGE.
CEA Cell Adhesion Molecule 6 (CEACAM6) belongs to the carcinoembryonic antigen (CEA) family whose members are glycosyl phosphatidyl inositol (GPI) anchored cell surface glycoproteins. Members of this family play a role in cell adhesion and are widely used as tumor markers in serum immunoassay determinations of carcinoma. CEACAM6 affects the sensitivity of tumor cells to adenovirus infection. The acts as a receptor for adherent-invasive E. coli adhesion to the surface of ileal epithelial cells in patients with Crohn's disease.
Specifications
| CEACAM6 | |
| Polyclonal | |
| Unconjugated | |
| CEACAM6 | |
| BGP; BGP-1; carcinoembryonic antigen related cell adhesion molecule 6; carcinoembryonic antigen-related cell adhesion molecule 6; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); CD66a; CD66c; CD66d; CD66e; CEA; CEACAM-1; CEACAM-3; CEACAM-5; CEACAM6; CEACAM-6; CEAL; CGM1; Cluster of Differentiation 66c; NCA; Non-specific crossreacting antigen; Normal cross-reacting antigen; pan CEACAM | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 100125369, 4680 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.2 | |
| P40199 | |
| CEACAM6 | |
| A synthetic peptide corresponding to residues in Human CEACAM6. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction